John J. Tanner, PhD

University of Missouri – Columbia (MU)

We study the structural biology and inhibition of proline metabolic enzymes. We are interested in developing inhibitors of proline metabolic enzymes as lead compounds for the development of drugs that target cancer metastasis. We would like to use the ICTS high throughput screening core.